Loading stock…

UBS Group AG (UBS) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

UBSUBS Group

Revenue FY25$47.9B

GROWTH RATING↗

WEAK31 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+13%8

Revenue, next 1Y+6%4

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+58%9

EPS growth, FY27E+13%7

EPS growth, FY28E+11%7

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 13%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Earnings are set to grow faster than sales (EPS about 13%/yr vs revenue 4%/yr), so margins should widen.

WATCH

Revenue grew 13%/yr over the last 3 years; forecasts see it cooling to 4%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 69% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Margin Expander

Growth is a weak point here: a business that is slowing. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

UBSUBS Group

Total return Current306%

Price return Current203%

MOMENTUM RATING↗

AVERAGE57 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-14%1

3-month return-7%4

YTD return+4%5

MID & LONG-TERM▾SCORE

% of 52-week high85%7

1-year return+18%7

3-year return+105%8

5-year return+215%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +105% over three years and +215% over five, ahead of 80% of the market.

It's up 18% over the past year, but 15% below its 52-week high. That is clearly ahead of the market.

WATCH

Returns sit at the market level over three months (-7%) and so far this year (+4%).

WEAKNESSES

The stock is underperforming over the past month (-14%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over the past month.

04Value

Are you paying a fair price for it?

Stop guessing on UBS. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

UBSUBS Group

Revenue FY25$47.9B

GROWTH RATING↗

WEAK31 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+13%8

Revenue, next 1Y+6%4

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+58%9

EPS growth, FY27E+13%7

EPS growth, FY28E+11%7

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 13%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Earnings are set to grow faster than sales (EPS about 13%/yr vs revenue 4%/yr), so margins should widen.

WATCH

Revenue grew 13%/yr over the last 3 years; forecasts see it cooling to 4%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 69% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Margin Expander

Growth is a weak point here: a business that is slowing. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

UBSUBS Group

Total return Current306%

Price return Current203%

MOMENTUM RATING↗

AVERAGE57 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-14%1

3-month return-7%4

YTD return+4%5

MID & LONG-TERM▾SCORE

% of 52-week high85%7

1-year return+18%7

3-year return+105%8

5-year return+215%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +105% over three years and +215% over five, ahead of 80% of the market.

It's up 18% over the past year, but 15% below its 52-week high. That is clearly ahead of the market.

WATCH

Returns sit at the market level over three months (-7%) and so far this year (+4%).

WEAKNESSES

The stock is underperforming over the past month (-14%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over the past month.

04Value

Are you paying a fair price for it?

Stop guessing on UBS. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

UBS Group AG

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on UBS. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on UBS. Get the full investment case.

Premium